Agoracom Blog

MedX Health Corp. $MDX.ca Announces 2019 Year End Results

Posted by AGORACOM-JC at 5:08 PM on Friday, June 12th, 2020
Home - MedX Health
  • Company reported revenue of $860,248 for the year ended December 31, 2019

MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) announced its results for the year ended December 31, 2019, which are also available on SEDAR (www.sedar.com).

The Company reported revenue of $860,248 for the year ended December 31, 2019, compared with revenue of $1,087,426 for the year ended December 31, 2018. Sales were lower in 2019 from both its SIAscopy skin assessment technology and therapeutic laser product lines. The Company reported a loss for the year ended December 31, 2019 of $3,276,350 or $0.02 per share compared with a loss of $4,186,573, or $0.03 per share for the year ended December 31, 2018.

For the three months ended December 31, 2019, the Company reported revenue of $181,362, compared with revenue of $275,193 reported in the three-month period in 2018. Revenue was higher than 2018 for the SIAscopy product line in the fourth quarter, while sales of therapeutic lasers were lower for the three-month period. The loss for the three months ended December 31, 2019 was $1,189,458, or $0.00 per share, compared with a loss of $1,015,240, or $0.01 per share for the three-month period ended December 31, 2018.

“The Company reduced spending during 2019 and was able to lower the loss for the year despite a decline in sales, particularly towards the end of the year,” noted Scott Spearn, CEO of MedX. “We are actively working with a number of partners to build revenue from the investment we made in our SIAscopy on DermSecure™ telemedicine platform, that is beginning to gain awareness in significant markets, and the capital we have raised to date in 2020 will enable us to capitalize on these opportunities in 2020 and beyond. While very positive about our future, we have experienced the impact from COVID-19 to date in 2020, particularly with respect to lower sales of our therapeutic laser products, and there is uncertainty as to the timing and extent of its impact during the remainder of 2020,” Mr. Spearn continued.

About MedX

MedX, headquartered in Mississauga, Ontario, is a leading medical device and software company focused on skin health with its SIAscopy on DermSecure™ telemedicine platform, utilizing its SIAscopy™ technology. SIAscopy is also imbedded in its products SIAMETRICS™, SIMSYS™, and MoleMate™, which MedX manufactures in its ISO 13485 certified facility. SIAMETRICS™, SIMSYS™, and MoleMate™ include hand-held devices that use patented technology utilizing light and its remittance to view up to 2 mm beneath suspicious moles and lesions in a pain free, non-invasive manner, with its software then creating real-time images for physicians and dermatologists to evaluate all types of moles or lesions within seconds. These products are Health Canada, FDA, TGA and CE cleared for use in Canada, the US, Australia, New Zealand, the European Union, Brazil and Turkey. MedX also designs, manufactures and distributes quality photobiomodulation therapeutic and dental lasers to provide drug-free and non-invasive treatment of tissue damage and pain. www.medxhealth.com.

This press release does not constitute an offer of any securities for sale. This press release contains certain forward-looking statements within the meaning of applicable Canadian securities legislation. These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ, including, without limitation, the company’s limited operating history and history of losses, the inability to successfully obtain further funding, the inability to raise capital on terms acceptable to the company, the inability to compete effectively in the marketplace, the inability to complete the proposed acquisition and such other risks that could cause the actual results to differ materially from those contained in the company’s projections or forward-looking statements. All forward looking statements in this press release are based on information available to the company as of the date hereof, and the company undertakes no obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this press release.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200612005534/en/

Scott Spearn, President and CEO
MedX Health Corp
905-670-4428 ext 229

Vale’s Canada Mines Set For More Battery-Electric Vehicle Trials SPONSOR: Lomiko Metals $LMR.ca $CJC.ca $SRG.ca $NGC.ca $LLG.ca $GPH.ca $NOU.ca

Posted by AGORACOM at 1:25 PM on Friday, June 12th, 2020

SPONSOR: Lomiko Metals is focused on the exploration and development of minerals for the new green economy such as lithium and graphite. Lomiko has an option for 100% of the high-grade La Loutre graphite Property, Lac Des Iles Graphite Property and the 100% owned Quatre Milles Graphite Property. Lomiko is uniquely poised to supply the growing EV battery market. Click Here For More Information

  • These trials will help steer business investment decisions in future years
  • The benefits from trials so far include:
  • Health and safety improvements for employees underground: EVs are much quieter than diesel vehicles and produce less heat and zero exhaust emissions. “From an operator comfort perspective, EVs are certainly an improvement,”
  • Cost savings: EVs can reduce underground ventilation demands and the associated operating and capital expenditure
  • Environmental benefits: EVs contribute to the reduction of greenhouse gas emissions.

By the end of 2020, Vale hopes to have upward of 20 battery-powered vehicles operating within its North Atlantic operations, according to Alex Mulloy, Mining Engineer within Vale’s Base Metals Technology and Innovation division.

The plan is for the electric vehicles (EVs) to be operating on a trial basis at its Creighton, Coleman, Copper Cliff, Garson and Thompson mines by the end of the year, with the company having already made significant headway on achieving this goal.

Vale is aligned with the Paris climate-change agreement, and committed to being carbon neutral by 2050, with a 33% cut in greenhouse gas emissions planned across the company by 2030. This is part of a strategy to invest at least $2 billion to combat climate change, which includes the use of battery-electric vehicles.

Vale has already tested Rokion’s battery-powered personnel carriers/utility vehicles at Creighton, while an Epiroc ST7 battery-powered vehicle and Artisan Z40 haul truck have been trialled underground at Coleman.

Mulloy said the green vehicles are going to be evaluated with feedback from operations, as well as operating data, to help Vale understand how they perform in terms of reliability, functionality and the benefits they can offer our people and the business.

The benefits from trials so far include:

  • Health and safety improvements for our employees underground: EVs are much quieter than diesel vehicles and produce less heat and zero exhaust emissions. “From an operator comfort perspective, EVs are certainly an improvement,” Mulloy said;
  • Cost savings: EVs can reduce underground ventilation demands and the associated operating and capital expenditure; and
  • Environmental benefits: EVs contribute to the reduction of greenhouse gas emissions.

“EVs certainly complement the efforts of the business in terms of greenhouse gas and carbon reduction,” Mulloy said. “It’s a great technology. Not only does it enable operational benefit and improvement, it also contributes to our greater goals of reducing our emissions and the impact on the environment.”

Natalie Kari, Principal Engineer, Strategic Electric Vehicle Implementation, said: “Exhaust emissions from diesel engines are one of the larger contributors to environmental pollution. EVs are an opportunity to increase safety by improving operating conditions and creating a safe work environment. Reducing noise, vibrations, heat, greenhouse gas emissions, and diesel particulate matter, while improving air quality, contributes to creating an attractive work environment for top talent.

“With increased challenging mine conditions at depth, EVs also provide an opportunity to sustain productivity by enabling mines to produce in areas that otherwise may not be feasible without these benefits, contributing towards mining for years to come.”

These trials will help steer business investment decisions in future years, according to Mulloy.

“Over the coming months, a number of large prime mover vehicles will be delivered,” he said. “When those vehicles arrive, it will be an exciting step in the journey because most of the question marks around the performance of EVs relate to the large vehicles, so that’ll be a chance for us to really put this technology to the test.”

Kari added: “Our company’s next major steps include collaborating with internal and external industry stakeholders towards safe implementation, comprehensive trial data collection and validation of a robust model towards a final approved five-year implementation strategy. With any new technology, investment in our people will be a priority to ensure they are equipped with the tools necessary for successful operation and maintenance.

“It is thrilling to be a part of leading this effort in a time of increased innovation and environmental awareness,” she continued. “The movement from traditional diesel to electric vehicle brings a feeling of social pride in creating a healthier workplace.”

SOURCE: https://im-mining.com/2020/06/11/vales-canada-mines-set-battery-electric-vehicle-trials/

Datametrex $DM.ca Received the Final Payment on Completed Shipping of COVID-19 Test Kit Order

Posted by AGORACOM-JC at 8:38 AM on Friday, June 12th, 2020
  • Company has received the full and final payment from its purchaser and completed shipping the first purchase order of COVID-19 test kits for a mining company employees in multiple jurisdictions outside of Canada, as announced on May 15th 2020
  • The total gross sales amount is approximately $500,000 CDN, excluding shipping

TORONTO, June 12, 2020 — Datametrex AI Limited (the “Company” or “Datametrex“) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that the Company has received the full and final payment from its purchaser and completed shipping the first purchase order (the “PO”) of COVID-19 test kits for a mining company employees in multiple jurisdictions outside of Canada, as announced on May 15th 2020.

The total gross sales amount is approximately $500,000 CDN, excluding shipping.

Under the terms of the PO, Datametrex sold to the purchaser an initial 10,000 units of the iONEBIO Inc. iLAMP Novel-CoV19 Detection Kit; 10,000 3 mL Universal Transport Medium (UTM®) Sterile Swabs with 16x100mm Skirted Tubes with Plastic Red Capture Caps, and 1 Real-Time PCR Detection System machine to analyze the samples. The iONEBIO test kits provide results within approximately 15 to 20 minutes.

All of the items are shipped directly from manufacturers to the purchaser’s mine operating sites. Security clearance backlogs continue to streamline as Governments align with the World Health Organization’s remarks on the importance of testing. Governments have urged mining companies to implement testing and screening their workforce to properly fight the virus in order to avoid further closures.

“The opportunity to use an advanced COVID-19 testing kits from our partners from Korea to support the diagnostic potential for populations provides an exciting opportunity for countries during this pandemic and the African continent,” says Marshall Gunter, CEO of the Company. “Datametrex is honored to be assisting in the health and welware of mine employees and local contractors.”

According to Africa Centres for Disease Control and Prevention (the “Africa CDC”), there are over 150,000 cases of COVID-19 throughout Africa and with this, Researchers at the African Center of Excellence for Genomics of Infectious Diseases (the “ACEGID”) and other research and public health partners, have announced to implement a Sentinel Project (the “Sentinal”) surveillance protocol for an early warning system in Africa. The Sentinel is the first of eight new projects selected, and it has three pillars are: (1) detect, (2) connect and (3) empower. And in the third pillar, the project will empower public health experts by training thousands of healthcare professionals to use the sentinel tools and deploy the diagnostic technologies for population-level COVID-19 testing, building on previous experiences of ACEGID and the Broad Institute in training over 900 individuals from around the world.

Datametrex’s mission is to provide tools that support companies in fulfilling their operational Health and Safety goals with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain.

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com).

Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Else Nutrition $BABY.ca Announces Listing on Frankfurt Stock Exchange $MAT $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 7:08 AM on Friday, June 12th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png
  • Announce that its common shares were accepted for listing on the Frankfurt Stock Exchange (FSE) under the trading symbol 0YL
  • FSE listing is expected to increase trading liquidity in the Company’s shares, as well as to assist in attracting investment by institutional and retail investors in Europe

VANCOUVER, BC, June 12, 2020 – ELSE NUTRITION HOLDINGS INC. (TSXV: BABY) (OTCQB: BABYF) (FSE: 0YL) (“Else” or the “Company“), is pleased to announce that its common shares were accepted for listing on the Frankfurt Stock Exchange (FSE) under the trading symbol 0YL. The Company’s common shares are now cross-listed on the TSX Venture Exchange, the OTCQB and the FSE. The FSE listing is expected to increase trading liquidity in the Company’s shares, as well as to assist in attracting investment by institutional and retail investors in Europe.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc, is a publicly-traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QB board under the trading symbol BABYF. Else’s Executive and Advisory Board includes leaders hailing from Abbott Nutrition, Mead Johnson, Boston Children’s Hospital, ESPGHAN (European Society for Pediatric Gastroenterology, Hepatology and Nutrition). Plum Organics, Tel Aviv University’s Sackler Faculty of Medicine, and Gastroenterology & Nutrition Institute of RAMBAM Medical Center.

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will”, “expect” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that listing on the FSE will create additional liquidity and attract additional investors in the European market. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements.  Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

VIDEO: Datametrex $DM.ca #COVID19 Test Kit Sales Of Approx $1.5M & 26,000 Units – Are Just PILOT PROJECTS

Posted by AGORACOM-JC at 6:43 PM on Thursday, June 11th, 2020

On April 16, Datametrex AI  announced it had obtained the rights to import and sell COVID-19 test kits from South Korea, due to a request for help from the Canadian Government who needed a partner with high-level security clearances.

On May 15, Datametrex AI reported its first sale of $500,000 for 10,000 units to a Canadian mining company.

By today’s interview (June 11) Datametrex has announced approximately $1,500,000 in sales, representing approximately 25,000 COVID-19 test kits.
Any company and their investors would be very happy with these results give the fact it’s Q3 sales (March 31 and Pre-COVID) were $810,000 strictly from Artificial Intelligence.

But CEO Marshall Gunter then dropped a bomb on us …. the ~25,000 Units and $1.5M in COVID-19 test kit sales are PILOT PROJECTS, the definition of which according to QUORA is:

A pilot project is an initial smaller scale implementation of a larger project that is used to work out issues and roadblocks prior to going all out with the full project.

Clearly, Datametrex has something potentially bigger in mind, assuming all goes well with these pilot projects.  How well are they going?  Who else are they talking to?  How far could the “full project” go?

The answers to those questions will come from our latest interview with Datametrex AI CEO, Marshall Gunter.  

Datametrex AI (DM: TSXV) is a great Canadian small cap technology company, who is giving small cap investors an opportunity to participate in the emerging world of Artificial Intelligence, as well as, the brand new world of COVID-19 testing.

Watch this interview or listen by Podcast on Apple, Google, Spotify or your favourite podcaster.

PyroGenesis $PYR.ca Signs Second Modelling Contract with New Iron Ore Pelletization Client $RTN $NOC $UTX $DDD.ca $SSYS $PRLB

Posted by AGORACOM-JC at 1:17 PM on Thursday, June 11th, 2020
  • Signed a second multi-phase torch modelling contract aimed at evaluating the performance of PyroGenesis’ proprietary torches in an existing iron ore industrial furnace with the goal of replacing existing fossil fuel burners with PyroGenesis’ plasma torches
  • The first phase is expected to be completed in approx. 8 to 10 weeks
  • This Contract is with another multi-billion-dollar producer of iron ore pellets (“ClientB”), whose name will remain confidential for competitive reasons
  • ClientB has over 100 burners in its existing facilities

MONTREAL, June 11, 2020 – PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V: PYR) (OTCQB: PYRNF) (FRA: 8PY), a high-tech company, (the “Company”, the “Corporation” or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch systems, is pleased to announce today that, further to its press releases dated March 4th, April 30th and May 19th, 2020, it has signed a second multi-phase torch modelling contract (the “Contract”), aimed at evaluating the performance of PyroGenesis’ proprietary torches in an existing iron ore industrial furnace with the goal of replacing existing fossil fuel burners with PyroGenesis’ plasma torches. The first phase is expected to be completed in approx. 8 to 10 weeks. This Contract is with another multi-billion-dollar producer of iron ore pellets (“ClientB”), whose name will remain confidential for competitive reasons. ClientB has over 100 burners in its existing facilities.

“This is the second press release announcing that a significant player in the iron ore pelletization industry has entered into a modeling contract with us, in the past few months,” said Mr. Peter Pascali, CEO and President of PyroGenesis. “This just underscores the tremendous impact our proprietary torch is having on the industry and, as we said in the past, this interest is spilling over into other industries as well (such as mining, metallurgy and cement industries). We continue to find that the proposition of reducing greenhouse gases emissions, and avoiding carbon taxes, with a simple bolt-on replacement of their current environmentally damaging fossil fuel burners, is too compelling to resist.  That, combined with the environmental pressure these industries are currently under (only recently a new trend has emerged where financial institutions are tying credit facilities and debt issuances to carbon reduction targets for multi-national industrial and mining conglomerates), has contributed significantly to this wave of interest and proposals.”

“In fact, it goes beyond avoiding carbon taxes,” said Mr. Pierre Carabin, CTO of PyroGenesis. “We see a global trend towards a zero-carbon economy, with the push coming not only from regulators but also from shareholders, investment funds and the general population.  As such, all the industry players we are talking to have aggressive internally set carbon reduction targets and are actively seeking commercially ready technical solutions that will have a minimal impact on their operations.  As such, we believe that PyroGenesis’ proprietary torches offer a relatively easy upgrade to existing industrial processes, such as with pelletizing furnaces, while offering major greenhouse gas reductions.  This is in addition to (i) the reduction in pollution from sulfur compounds and heavy metals resulting from heavy fuel oil burners, and (ii) a cost advantage to those companies that have access to affordable hydro power as a replacement to expensive bunker fuel.”

This modelling contract, once again, is geared to demonstrating that replacing fossil fuel burners with PyroGenesis’ proprietary plasma torches will not have any detrimental effects on ClientB’s process or their furnaces. Both ClientB and the Company do not anticipate any detrimental effects. As previously disclosed,  for a separate iron ore pelletization Client (“ClientA”), replacing fossil fuel burners with  PyroGenesis’ proprietary plasma torches could theoretically result in a CO2 reduction in excess of 350,000 tons per year per plant (which is equivalent to removing 76,000 cars1 from the road), while at the same time projecting significant cost savings. In the case of ClientB, the switch to plasma torches will also result in the additional benefit of significantly reducing the emission of another pollutant; sulfur dioxide (SO2).

“Although, there is no guarantee of successful conclusion, nor of the timeframe in which this might occur, given our significant plasma expertise, our specific knowledge of the application, and the challenges in these industries, we are highly confident that there will be a positive outcome as a result of these modeling contracts in the very near future,” noted Mr. Pascali. “If and when this outcome is eventualized, PyroGenesis will execute it in a very conservative, strategic and determined manner, with the primary goal being to maximize customer satisfaction and shareholder value. Everything will be geared to securing success, market penetration, and ensuring PyroGenesis’ long-term viability as the preeminent supplier of torches to the industry. Our proprietary position, built upon a strong process patent, provides us with a significant advantage in pursuing this goal.”

Although there is no guarantee of future contracts, PyroGenesis has already not only contacted its existing suppliers in anticipation of any orders of size, but is also actively expanding their supplier base to mitigate any supply chain risk of significant orders. PyroGenesis’ management is confident that the Company is now well positioned to address any anticipated demand.

Pelletization is the process in which iron ore is concentrated before shipment, thus significantly reducing the cost of transportation. In conventional technologies, the process heat is provided by fuel oil or natural gas burners (both environmentally damaging). The combustion, in the burners, of fossil fuels results in the production of greenhouse gases, mainly CO2. Plasma torches, by contrast, utilize renewable electricity and as such offer an environmentally attractive alternative to fossil fuel burners.

About PyroGenesis Canada Inc.

PyroGenesis Canada Inc., a high-tech company, is the world leader in the design, development, manufacture and commercialization of advanced plasma processes and products. We provide engineering and manufacturing expertise, cutting-edge contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, advanced materials (including 3D printing), oil & gas, and environmental industries. With a team of experienced engineers, scientists and technicians working out of our Montreal office and our 3,800 m2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. Our core competencies allow PyroGenesis to lead the way in providing innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. Our operations are ISO 9001:2015 and AS9100D certified, and have been since 1997. PyroGenesis is a publicly-traded Canadian Corporation on the TSX Venture Exchange (Ticker Symbol: PYR) and on the OTCQB Marketplace. For more information, please visit www.pyrogenesis.com.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward- looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Corporation’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Corporation with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Corporation’s ongoing filings with the securities regulatory authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Corporation undertakes no obligation to publicly update or revise any forward- looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws. Neither the TSX Venture Exchange, its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) nor the OTCQB accepts responsibility for the adequacy or accuracy of this press release.

SOURCE PyroGenesis Canada Inc.

For further information please contact:
Rodayna Kafal, Vice President Investors Relations and Strategic Business Development
Phone: (514) 937-0002, E-mail: [email protected]

VIDEO: ImagineAR $IP.ca #AR, “Sports 2.0” & TikTok – NEXT SUPER STOCK Livestream 6/10/20 $SEV.ca $VST.ca $YDX.ca $NTAR.ca

Posted by AGORACOM-JC at 11:56 AM on Thursday, June 11th, 2020
http://www.smallcapepicenter.com/imagine%20ar%20squre.jpg

Why Imagine AR?

(IP:CSE) (IPNFF:OTCQB)

  • ImagineAR Has Already Started Commercializing Its Augmented Reality Platform
  • Clients Include: 
    • NBA Sacramento Kings
    • Mall of America
    • AT&T Shape
    • Basketball Hall Of Fame
    • Milwaukee AutoShow
  • Microsoft Authorized Co-Sell Partner
  • Closed Major Financing In Q1 2020
  • Enables businesses of any size to create and implement their own AR campaigns with no programming or technology experience
  • ImagineAR is now well positioned to further commercialize and capitalize on massive demand for Augmented Reality
  • Signed five year $300,000USD licensing agreement with SlapItOn to provide Augmented Reality for athletes and celebrities to engage fans
  • Announced partnership with Engaged Nation, an award winning leader in digital engagement marketing for Casinos
  • Announced partnership with North Highland, a top ranked global consulting firm with over 5,000 consultants and 70 offices around the world
    • North Highland was ranked on the Forbes 2020 America’s Best Management Consulting Firms list, placing in seven categories, including one of only 31 firms ranked for Internet, Media and Entertainment.

Loncor Files NI 43-101 Technical Report on Imbo Project, Confirming Inferred Mineral Resource Increase to 2.5 Million Ounces $LN.ca $ABX.ca $TECK.ca $RSG $NGT.to $GOLD $NEM

Posted by AGORACOM at 10:07 AM on Thursday, June 11th, 2020
  • The Imbo inferred mineral resource increased by 49% to 2.5 million ounces (30.65 million tonnes grading 2.54 g/t Au). 76.29% of this gold resource is attributable to Loncor via its 76.29% interest in the Imbo Project.
  • 76.29% of this gold resource is attributable to Loncor via its 76.29% interest in the Imbo Project.
  • A planned drill program will look to add to the Adumbi resource over the next twelve months.

TORONTO, June 10, 2020 (GLOBE NEWSWIRE) — Loncor Resources Inc. (“Loncor” or the “Company“) (TSX: “LN”; OTCQB: “LONCF”) announces that it has filed on SEDAR an independent National Instrument 43-101 technical report (the “Technical Report”) relating to the Company’s Imbo Project, in particular, the updated gold mineral resource estimates for the Imbo Project reported in the Company’s April 17, 2020 press release.  The Technical Report, which was prepared by Minecon Resources and Services Limited, has an effective date of April 17, 2020 and is entitled “Independent National Instrument 43-101 Technical Report on the Imbo Project, Ituri Province, Democratic Republic of the Congo”.

Highlights from April 17, 2020 press release confirmed in Technical Report:

  • The Imbo Project inferred mineral resource increased by 49% to 2.5 million ounces of gold (30.65 million tonnes grading 2.54 g/t Au).  76.29% of this gold resource is attributable to Loncor via its 76.29% interest in the Imbo Project. 
  • Within the Imbo Project, the Adumbi deposit inferred mineral resource increased by 61% to 2.19 million ounces of gold (28.97 million tonnes grading 2.35 g/t Au) (the Adumbi deposit is one of the three deposits at Imbo currently with a resource). 
  • A planned drill program will look to add to the Adumbi resource over the next twelve months.

The Imbo mineral resources are in addition to Loncor’s resources at its Makapela Project (which is 100%-owned by Loncor) where there is an indicated mineral resource of 614,200 ounces of gold (2.20 million tonnes grading 8.66 g/t Au) and an inferred mineral resource of 549,600 ounces of gold (3.22 million tonnes grading 5.30 g/t Au). 

Arnold Kondrat, CEO of Loncor, stated: “This filing of the 43-101 represents the culmination of many years of persistence by the Loncor team in the Ngayu greenstone belt.  We believe this region is one of the few remaining areas around the world where Tier 1 gold deposits can still be discovered, built and mined profitably as shown by Barrick Gold at the Kibali mine.  Over the next 12 months, Loncor will look to drive forward with a drill program at the Adumbi deposit, with the aim of significantly increasing the current resource, while simultaneously awaiting with interest news on the imminent drilling program at the drill targets defined by our Joint Venture partner Barrick Gold.”

About Loncor Resources Inc.
Loncor is a Canadian gold exploration company focussed on the Ngayu Greenstone Belt in the North East of the Democratic Republic of the Congo (the “DRC”).  The Loncor team has over two decades of experience of operating in the DRC.  Ngayu has numerous positive indicators based on the geology, artisanal activity, encouraging drill results and an existing gold resource base.  The area is 220 kilometres southwest of the Kibali gold mine, which is operated by Barrick Gold (Congo) SARL (“Barrick”).  In 2019, Kibali produced record gold production of 814,000 ounces at “all-in sustaining costs” of US$693/oz.  Barrick has highlighted the Ngayu Greenstone Belt as an area of particular exploration interest and is moving towards earning 65% of any discovery in 1,894 km2 of Loncor ground that they are exploring.  As per the joint venture agreement signed in January 2016, Barrick manages and funds exploration on the said ground at the Ngayu project until the completion of a pre-feasibility study on any gold discovery meeting the investment criteria of Barrick.  In a recent announcement Barrick highlighted six prospective drill targets and are moving towards confirmation drilling in 2020. Subject to the DRC’s free carried interest requirements, Barrick would earn 65% of any discovery with Loncor holding the balance of 35%.  Loncor will be required, from that point forward, to fund its pro-rata share in respect of the discovery in order to maintain its 35% interest or be diluted.

In addition to the Barrick JV, certain parcels of land within the Ngayu project surrounding and including the Makapela and Adumbi deposits have been retained by Loncor and do not form part of the joint venture with Barrick. Barrick has certain pre-emptive rights over the Makapela deposit.  Loncor’s Makapela deposit (which is 100%-owned by Loncor) has an indicated mineral resource of 614,200 ounces of gold (2.20 million tonnes grading 8.66 g/t Au) and an inferred mineral resource of 549,600 ounces of gold (3.22 million tonnes grading 5.30 g/t Au).  Adumbi and two neighbouring deposits hold an inferred mineral resource of 2.5 million ounces of gold (30.65 million tonnes grading 2.54 g/t Au), with 76.29% of this resource being attributable to Loncor via its 76.29% interest in the project.  

Resolute Mining Limited (ASX/LSE: “RSG”) owns 26% of the outstanding shares of Loncor and holds a pre-emptive right to maintain its pro rata equity ownership interest in Loncor following the completion by Loncor of any proposed equity offering. 

Additional information with respect to Loncor and its projects can be found on Loncor’s website at www.loncor.com.

Qualified Person
Peter N. Cowley, who is President of Loncor and a “qualified person” as such term is defined in National Instrument 43-101, has reviewed and approved the technical information in this press release. 

Technical Reports
Additional information with respect to the Company’s Imbo Project is contained in the technical report of Minecon Resources and Services Limited dated April 17, 2020 and entitled “Independent National Instrument 43-101 Technical Report on the Imbo Project, Ituri Province, Democratic Republic of the Congo”.  A copy of the said report can be obtained from SEDAR at www.sedar.com. 

$KABN.ca Systems NA – The Company that’s Protecting Identity as YOUR Basic Human Right

Posted by AGORACOM-JC at 10:01 AM on Thursday, June 11th, 2020
This image has an empty alt attribute; its file name is image-3.png

While investing in small cap companies comes with certain inherent risks, it’s not high stakes, low chance gambling. In fact, practically every billion-dollar large cap company started off as a penny stock.

For the savvy retail investor or day trader, they know full well that emerging financial technology-based companies have, for the past two decades-plus, offered the highest returns with relatively low risk mitigation…even despite the dot com bubble crash of the early 2000’s.

Today, a lot of smart money is funneling into forward-thinking companies that are fulfilling an immediate need to provide real world solutions to identity fraud and creating value through data validation.

Now, an innovative, Toronto-based company is making real things happen to protect consumers, companies, and capital.

KABN (pronounced ‘Cabin’) Systems NA (CSE:KABN, Forum) is already on the forefront of developing cutting-edge blockchain-supported and biometric customized identity solutions software. Bear in mind, this fintech company is not in conflict or cooperation with companies trying to use your data. They are the protectors of your data. Here’s how they do it.

Their world-class suite of products and services work seamlessly across all channels and, most importantly, all demographic groups. Simply put, KABN’s software apps and digital banking processes can work for everyone.

KABN works differently than other companies in this space. How? They offer a unique, comprehensive, and integrated suite of identity, financial, and loyalty services.

Here’s the starting lineup. Liquid Avatar – powered by KABN ID – provides an ‘Always On’, biometrically-based, privacy-compliant, identity validation and verification platform which enables users to continuously and confidently prove themselves to the online community, exchanges, and other services. KABN ID is the backbone to its financial, loyalty, and engagement solutions including the KABN Prepaid Card program and KABN KASH – an innovative cash-back program where users are connected to online merchants for savings when they shop.



(Click image to enlarge. *Estimates are for the North American market ONLY.)


Why Digital Identity Matters

Identity is what makes people unique, but since the inception of the internet, digital identity has often been an afterthought. With today’s acceleration of online commerce, education, healthcare, government, and other services tailored to the individual, digital identity and the data that surrounds it is online “gold”. KABN says they believe that ownership of identity is a “basic human right and individuals should be the primary beneficiary of any use of their identity.” This is what sets KABN apart.

In the conventional world, it’s easy to prove who you are either by visual or traditional identity verification. It’s a process that most people are accustomed to following.

In today’s digital world, it’s not that easy to prove “you are you”. Identity verification is managed on a site-by-site basis and users are often required to deliver sensitive documents to unknown third parties, potentially reducing the value of their identity and increasingly exposing themselves to the risk of identity fraud.“KABN believes that ownership of identity is a basic human right and individuals should be the primary beneficiary of any use of their identity.”Digital Identity “Friction”

In the digital data world, it’s all about the pennies, nickels, dimes, and quarters and the
ability to passively and actively generate revenues through everyday consumer activities. The Company says that, at present, the digital identity space has not satisfactorily addressed both the consumer and commercial stakeholder needs. Both are vital to consider, and these include:

Consumer Identity Needs…

  • to make ID verification reusable
  • to put me in control of my private data
  • to help me manage my public data
  • to reduce identity fraud

Commercial Identity Needs…

  • to reduce friction of screening consumer users
  • to simplify user verification
  • to streamline compliance resources
  • to manage user Personally Identifiable Information (PII) efficiently

KABN’s Suite of Solutions: KABN ID, Liquid Avatar, the KABN Prepaid Visa card, and KABN KASH.

KABN ID

KABN ID is a proprietary, blockchain, and biometrically-based digital identity verification platform for both commercial clients and consumers users. KABN ID is a complete shift in thinking for identity validation as KABN ID provides a reusable, bank-grade identity verification for the individual user, at no cost to the consumer.

KABN ID is a global 24/7/365 verified online ID that is controlled by the client. The online identity service that is regulatory compliant, blockchain and biometrically-based, and is available at no cost to the consumer.

Users own and control the use of their verified identification, no personally identifiable information is ever transferred without authorization, and it provides organizations with an “Always On” KYC / AML (Know Your Customer / Anti Money Laundering) validation and verification process.

Liquid Avatar

Data is indeed the new “gold”. As users are presented value offerings and other services based on their public data profiles and system generated data, KABN, in turn, offers information services that are delivered directly to the user. User data is never sold or rented and remains part of the KABN Network.

A Liquid Avatar is a multi-layered, visual technology icon or token that contains information that can be linked, authenticated, and shared. When you share a Liquid Avatar, you automatically attach public data that will allow permission-based private data to be authenticated.

Liquid Avatars include a Visual or Presentation Layer – Public Data Layer, Private Data Layer, and a Security and Authentication Layer.

KABN Prepaid Visa Card

As part of KABN’s commitment to providing its Customers with innovative, permission-based values, KABN is introducing its first financial services program, the KABN Prepaid Visa card and Mobile Banking Wallet program that supports both digital and traditional currencies.

KABN Prepaid Visa cardholders will be able to spend in-store, online, and access ATMs globally, wherever Visa is accepted.

KABN Card Features include:

  • a digital currency-linked prepaid Visa card
  • a multiple currency banking wallet
  • KABN KASH cashback program and other innovative services

and, global access – anywhere that Visa is accepted worldwide.

KABN KASH

KABN KASH is a robust engagement portal which includes a cash-back program. Here users are able shop at some of North America’s top online merchants and receive cash back on their KABN Card. Customers will also receive updates on special offers and unique deals exclusive to KABN KASH.

KABN KASH Features include:

  • an exclusive customer portal
  • cashback rewards
  • special offers
  • exclusive opportunities & experiences
  • and instant savings alert messaging.

In the News: “KABN Systems to take over Torino Power Solutions”

Kabn Systems North America – a fintech company leveraging biometric ID verification – has signed an agreement with Torino Power Solutions to execute a reverse takeover (RT) as it prepares to launch a digital banking and financial services platform.

The platform will consist of continuous ID validation and verification processes. These include:

  • Liquid Avatar – powered by KABN ID – which is based on biometrics and blockchain
  • the KABN Prepaid Visa Card, which acts as a payment card and digital wallet for multi-currency transactions with digital or fiat currencies
  • and KABN KASH, a loyalty and customer engagement platform.

The technology is just not cool…it’s comprehensive.

From the Executive Team

In a lively and informative interview with Stockhouse Editorial, KABN’s Chief Executive Officer, Ben Kessler talked about a variety of timely Company happenings, including not only the experience but the innovative ideas they’re bringing to the digital identity management space. Ben Kessler commented:

“Our focus is on our three core strengths – Reach, a Unique Business Approach and Team. With our senior management team, I think the great thing we all bring is some extremely strong skillsets and experiences and we all see things, in some ways, slightly different. And that’s a good thing.”

Kessler also highlighted the three unique attributes that he believes will make KABN successful:

“First, our reach. It covers 100 percent of the addressable online market which is approximately 300 million people in North America, so we don’t have to go looking to provide a service to people who may not want it. Identity is becoming more important. Second, we have a unique business approach. We want to empower consumers to manage and control their identity and find ways to create value and opportunity from that identity. Our business is to empower constituents and commercial clients, as well. The third thing is, we’ve just got a simply outstanding team. We’ve all been doing this for a lot of years and in my career, I’ve never had a better crew of people that I’ve ever worked with. We’ve got a great team and advisors that are all uniquely focussed on succeeding.”

In Closing

There aren’t a lot of companies like KABN that offer a unique ground-floor investment opportunity in one of the most vital sectors of the New Economy – digital identity protection. The team says they’re excited and completely engaged in doing what’s best for investors, and it shows. Afterall, isn’t that what it’s all about? Bringing ‘value and opportunity’ to one of the most blue-sky digital global markets available today.

Source: https://stockhouse.com/news/newswire/2020/06/11/the-company-that-s-protecting-identity-as-your-basic-human-right

Psilocybin Seems to Turn Down the “Ego Center” in Brain SPONSOR: MOTA Ventures $MOTA.ca $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Posted by AGORACOM at 9:52 AM on Thursday, June 11th, 2020

SPONSOR: Mota Ventures Corp is an established natural health products company focused in the CBD and psychedelic medicine sectors. Through their powerful eCommerce business, Mota is a leading direct-to-consumer provider of a wide range of natural health products throughout the United States and Europe. Click Here for More Info

In a new study, Johns Hopkins Medicine researchers analyzed the brain scans of people after they took psilocybin, the active compound in psychedelic (magic) mushrooms, to see what happens in the brain when people are on psychedelics.

The team focused on a part of the brain known as the claustrum, taken from the Latin word for “hidden or shut away.” The claustrum is an extremely thin sheet of neurons deep within the cortex, yet it reaches out to every other region of the brain.

Its true purpose remains “hidden away” as well, with researchers speculating about its functions. For example, Dr. Francis Crick, the British biologist and neuroscientist who proposed the double helix structure of the DNA molecule, believed that the claustrum was the seat of consciousness, responsible for awareness and sense of self.

What is known is that this region contains a large number of receptors targeted by psychedelic drugs such as LSD or psilocybin.

To see what happens in the claustrum when people are on psychedelics, the researchers compared the brain scans of people after they took psilocybin with their scans after taking a placebo.

The scans after psilocybin use showed that the claustrum was less active, meaning the area of the brain believed responsible for setting attention and switching tasks is turned down when on the drug.

The researchers say that this ties in with what people report as typical effects of psychedelic drugs, including feelings of being connected to everything and reduced senses of self or ego.

“Our findings move us one step closer to understanding mechanisms underlying how psilocybin works in the brain,” says Frederick Barrett, Ph.D., assistant professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine and a member of the school’s Center for Psychedelic and Consciousness Research.

“This will hopefully enable us to better understand why it’s an effective therapy for certain psychiatric disorders, which might help us tailor therapies to help people more.”

Because of its deep-rooted location in the brain, the claustrum has been difficult to access and study. Last year, Barrett and his colleagues at the University of Maryland, Baltimore, developed a method to detect brain activity in the claustrum using functional magnetic resonance imaging (fMRI).

In this study, the researchers used fMRI with 15 people and observed the claustrum brain region after the participants took either psilocybin or a placebo. They found that psilocybin reduced neural activity in the claustrum by 15% to 30%.

This reduced activity also appeared to be linked to the stronger subjective effects of the drug, such as emotional and mystical experiences. The team also found that psilocybin changed the way that the claustrum communicated with brain regions involved in hearing, attention, decision-making and remembering.

With the highly detailed imaging of the claustrum provided by fMRI, the researchers hope to look at this mysterious brain region in people with certain psychiatric disorders such as depression and substance use disorder.

The aim of this research would be to see what roles, if any, the claustrum plays in these conditions. The team also plans to observe the claustrum’s activity when under the influence of other psychedelics, such as salvinorin A, a hallucinogen derived from a Mexican plant.

The findings are published online in the journal NeuroImage.

Source: Johns Hopkins Medicine

https://psychcentral.com/news/2020/06/06/psilocybin-seems-to-turn-down-ego-center-in-brain/157165.html